BTIG raised the firm’s price target on MoonLake Immunotherapeutics (MLTX) to $81 from $71 and keeps a Buy rating on the shares. The firm ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Palo Alto Networks (NasdaqGS:PANW) from Buy to Neutral. Analyst Price Forecast Suggests 22.11% Upside As of December 23, 2024, ...

After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued ...

Kepler has recently reduced Frontline Plc (FRO) stock to Hold rating, as announced on December 12, 2024, according to Finviz. Earlier, on October 7, 2024, BTIG Research had raised the stock from a ...

HashiCorp Inc (HCP) stock saw a modest uptick, ending the day at $34.33 which represents a slight increase of $0.01 or 0.03% from the prior close of $34.32. The stock opened at $34.3 and touched a low ...

Carisma Therapeutics, Inc. (NASDAQ:CARM – Get Free Report) has earned an average recommendation of “Hold” from the seven ...

International Assets Investment Management LLC lowered its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 95.3 ...

KeyBanc raised the firm’s price target on DoorDash (DASH) to $225 from $180 and keeps an Overweight rating on the shares. The firm says the ...